What Researchers Did
Researchers performed a quality assessment of existing literature to determine the best management and treatment strategies for osteonecrosis in children and adolescents with acute lymphoblastic leukemia.
What They Found
They found that a randomized controlled trial indicated osteonecrosis could be prevented by intermittent corticosteroid administration. However, studies on interventions after onset were of low quality, with seven studies describing non-surgical options (5 bisphosphonates, 1 hyperbaric oxygen, 1 prostacyclin analogs) and five focusing on surgical interventions, none of which provided definite conclusions.
What This Means for Canadian Patients
Canadian patients with acute lymphoblastic leukemia may benefit from discontinuous steroid scheduling to prevent osteonecrosis. However, current evidence is insufficient to provide clear guidance on effective treatments once osteonecrosis has developed.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
The primary limitation is the low quality and lack of safety and efficacy studies for interventions after the onset of osteonecrosis, preventing definitive conclusions on treatment.